ArticleMultiple sclerosis journal - experimental, translational and clinical

Does the Multiple Sclerosis Impact Scale-29 (MSIS-29) have the range to capture the experience of fully ambulatory multiple sclerosis patients? Learnings from the ASCLEPIOS studies.

Antoine Regnault et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.